All In Biotech

Drug Trial Radar · NCT01073228

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

A Randomized, Double-blind, Placebo-Controlled, Parallel, 24-Week, Phase 2 Study of Three Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo in Subjects With Mild to Moderate Probable Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Apr 25, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 409 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

409

Actual

Start

Apr 2010

Primary completion

Nov 2011

Study completion Feb 2012

Sponsor

Lead sponsor
FORUM Pharmaceuticals IncIndustry
Sponsor type
Industry
Collaborators
INC Research Limited
First posted
Feb 23, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.

Conditions

  • Alzheimer's Disease
  • Central Nervous System Diseases
  • Cognition

Interventions

  • EVP-6124Drug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Alzheimer's Disease Assessment Scale-Cognitive subscale-13 (ADAS-cog-13)Time frame: Day -7, Baseline, 4, 12, 18, 23 Weeks

Locations

54 sites in 5 countries. Site status is shown where the registry gives one.

  • HOPE Research Institute

    Phoenix, Arizona

  • Catalina Research Institute

    Chino, California

  • ATP Clinical Research

    Costa Mesa, California

  • University of California, Irvine

    Orange, California

  • Radiant Research

    Santa Rosa, California

  • Research Center for Clinical Studies, Inc.

    Norwalk, Connecticut

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Meridien Research

    Brooksville, Florida

  • Brain Matters Research

    Delray Beach, Florida

  • MD Clinical

    Hallandale, Florida

  • Galiz Research

    Miami Springs, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Compass Research, LLC

    Orlando, Florida

  • Princeton Medical Institute

    Princeton, New Jersey

  • Memory Enhancement Center of NJ

    Toms River, New Jersey

  • Brooklyn Medical Institute

    Brooklyn, New York

  • Social Psychiatry Research Institute

    Brooklyn, New York

  • Advanced Bio Behavioral Sciences Inc.

    Elmsford, New York

  • University of Rochester Medical Center at MCH

    Rochester, New York

  • Columbus Research and Wellness Institute

    Columbus, Ohio

  • Summit Research Network

    Portland, Oregon

  • FutureSearch Trials of Dallas, L.P.

    Dallas, Texas

  • Grayline Clinical Drug Trials

    Wichita Falls, Texas

  • The Memory Clinic

    Bennington, Vermont

  • The Center for Excellence in Aging and Geriatric Health

    Williamsburg, Virginia

  • Clinical Site 1

    Bucharest, Romania

  • Clinical Site 2

    Bucharest, Romania

  • Clinical Site 3

    Bucharest, Romania

  • Clinical Site 4

    Bucharest, Romania

  • Clinical Site 5

    Bucharest, Romania

  • Site not named

    Iași, Romania

  • Site not named

    Oradea, Romania

  • Site not named

    Târgu Mureş, Romania

  • Site not named

    Kazan', Russia

  • Clinical Site 1

    Moscow, Russia

  • Clinical Site 2

    Moscow, Russia

  • Clinical Site 1

    Saint Petersburg, Russia

  • Clinical Site 2

    Saint Petersburg, Russia

  • Clinical Site 3

    Saint Petersburg, Russia

  • Clinical Site 4

    Saint Petersburg, Russia

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.